NO944417L - Kalsium kanalblokkerende polypeptider fra Filistata hibernalis - Google Patents

Kalsium kanalblokkerende polypeptider fra Filistata hibernalis

Info

Publication number
NO944417L
NO944417L NO944417A NO944417A NO944417L NO 944417 L NO944417 L NO 944417L NO 944417 A NO944417 A NO 944417A NO 944417 A NO944417 A NO 944417A NO 944417 L NO944417 L NO 944417L
Authority
NO
Norway
Prior art keywords
calcium channel
channel blocking
hibernalis
blocking polypeptides
filistata hibernalis
Prior art date
Application number
NO944417A
Other languages
English (en)
Norwegian (no)
Other versions
NO944417D0 (no
Inventor
Steven D Heck
Ii Deane M Nason
Robert T Ronau
Nicholas Alex Saccomano
Robert A Volkmann
Original Assignee
Pfizer
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Nps Pharma Inc filed Critical Pfizer
Publication of NO944417D0 publication Critical patent/NO944417D0/no
Publication of NO944417L publication Critical patent/NO944417L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Insects & Arthropods (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO944417A 1992-05-21 1994-11-18 Kalsium kanalblokkerende polypeptider fra Filistata hibernalis NO944417L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88707392A 1992-05-21 1992-05-21
PCT/US1993/003921 WO1993023428A1 (en) 1992-05-21 1993-04-30 Calcium channel blocking polypeptides from filistata hibernalis

Publications (2)

Publication Number Publication Date
NO944417D0 NO944417D0 (no) 1994-11-18
NO944417L true NO944417L (no) 1994-11-18

Family

ID=25390404

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944417A NO944417L (no) 1992-05-21 1994-11-18 Kalsium kanalblokkerende polypeptider fra Filistata hibernalis

Country Status (26)

Country Link
US (1) US5804554A (de)
EP (1) EP0672056B1 (de)
JP (1) JP2572715B2 (de)
KR (1) KR950701647A (de)
CN (1) CN1034123C (de)
AT (1) ATE155488T1 (de)
AU (1) AU668170B2 (de)
BR (1) BR9306388A (de)
CA (1) CA2134889C (de)
CZ (1) CZ284794A3 (de)
DE (1) DE69312320T2 (de)
DK (1) DK0672056T3 (de)
EG (1) EG20275A (de)
ES (1) ES2105261T3 (de)
FI (1) FI932284L (de)
GR (1) GR3024690T3 (de)
HU (1) HUT64570A (de)
IL (1) IL105694A (de)
MX (1) MX9302925A (de)
MY (1) MY108890A (de)
NO (1) NO944417L (de)
NZ (1) NZ252452A (de)
RU (1) RU2106358C1 (de)
TW (1) TW336938B (de)
WO (1) WO1993023428A1 (de)
ZA (1) ZA933493B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5461032A (en) * 1991-03-01 1995-10-24 Fmc Corporation Insecticidally effective peptides
IL104419A0 (en) * 1992-01-24 1993-05-13 Fmc Corp Insecticidally effective peptides
US5457178A (en) * 1993-07-07 1995-10-10 Fmc Corporation Insecticidally effective spider toxin
US5756459A (en) * 1995-06-07 1998-05-26 Fmc Corporation Insecticidally effective peptides isolatable from phidippus spider venom
CO5180581A1 (es) * 1999-09-30 2002-07-30 Pfizer Prod Inc Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
US8173772B2 (en) * 2005-12-30 2012-05-08 Spiber Technologies Ab Spider silk proteins and methods for producing spider silk proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5239059A (en) * 1991-05-10 1993-08-24 The Children's Hospital Of Philadelphia Ion-channel forming peptides

Also Published As

Publication number Publication date
JPH07503735A (ja) 1995-04-20
FI932284A7 (fi) 1993-11-22
DK0672056T3 (da) 1997-12-08
GR3024690T3 (en) 1997-12-31
RU94046023A (ru) 1996-10-10
ES2105261T3 (es) 1997-10-16
FI932284L (fi) 1993-11-22
CN1080931A (zh) 1994-01-19
JP2572715B2 (ja) 1997-01-16
IL105694A (en) 1998-02-22
EP0672056A1 (de) 1995-09-20
RU2106358C1 (ru) 1998-03-10
EG20275A (en) 1998-05-31
EP0672056B1 (de) 1997-07-16
MX9302925A (es) 1993-11-01
HUT64570A (en) 1994-01-28
CA2134889A1 (en) 1993-11-25
BR9306388A (pt) 1998-09-15
KR950701647A (ko) 1995-04-28
CZ284794A3 (en) 1995-08-16
IL105694A0 (en) 1993-09-22
ZA933493B (en) 1994-11-21
AU668170B2 (en) 1996-04-26
CN1034123C (zh) 1997-02-26
TW336938B (en) 1998-07-21
ATE155488T1 (de) 1997-08-15
DE69312320D1 (de) 1997-08-21
AU4117893A (en) 1993-12-13
WO1993023428A1 (en) 1993-11-25
FI932284A0 (fi) 1993-05-19
CA2134889C (en) 1998-03-31
NO944417D0 (no) 1994-11-18
HU9301476D0 (en) 1993-09-28
DE69312320T2 (de) 1997-10-30
MY108890A (en) 1996-11-30
US5804554A (en) 1998-09-08
NZ252452A (en) 1996-07-26

Similar Documents

Publication Publication Date Title
AU9536898A (en) 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the holesterin-ester transfer protein
DK0778890T3 (da) DNA, som koder for en human calciumkanal-alpha-1E-underenhed
NO864241D0 (no) Fremgangsmaate ved bleking av cellulosemasse eller fraksjon derav, anlegg til bruk ved gjennomfoeringen av fremgangsmaaten og skruepresse, saerlig til bruk ved fremgangsmaaten henholdsvis i anlegget.
TW271442B (de)
NO944417L (no) Kalsium kanalblokkerende polypeptider fra Filistata hibernalis
NO892029D0 (no) Fremgangsmaate ved spesifikk genetisk manipulering av mikroorganisme.
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
ATE265861T1 (de) Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung
NO951691L (no) Kalsiumkanal-blokkerende polypeptider fra Theraphosidal aphonopelma
AU3364297A (en) Ointments for treating suppurative lesions, burns and trophic ulcers at ll stages, preparation and applications of same
WO1994021273A3 (de) VERWENDUNG VON ANGIOGENIN UND/ODER α1-MICROGLOBULIN UND/ODER KOMPLEMENTFAKTOR D ZUR BEGRENZUNG DER SEKRETION VON PROTEINEN
NO950293L (no) Kalsiumkanalblokkerende polypeptid fra Agelenopsis aperta
NO882884L (no) Fremgangsmaate ved kontroll av plantesykdommer og mikroorganismer i naervaer av planter.
DE69129042D1 (de) Wachstums-kontrolle von fadenformigen mikroorganismen.
AU7251587A (en) Compositions for treating the symptoms of or preventing the common cold